Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
Articles by Patricia Inácio, PhD
PhotoPharmics plans to open, possibly this summer, a pivotal Phase 3 clinical trial of its light-based and noninvasive Celeste device…
New research suggests that brain inflammation is the likely reason antibody-based therapies are ineffective in clinical trials for people with…
Inbrain Neuroelectronics has raised $16.8 million in Series A financing to support moving into clinical testing a new neuromodulation device…
The National Institutes of Health (NIH) has awarded a $5 million grant to researchers investigating whether an artificial intelligence tool might…
A University of Alberta pharmacology professor and researcher will use a CA $1.04 million grant to investigate the potential role…
A grant from the Michael J. Fox Foundation (MJFF) will help Clene Nanomedicine to advance in development CNM-Au8, its cellular energy-promoting, investigational …
Changes in the composition of fat molecules on the membranes of nerve cells appear to change how the alpha-synuclein protein interacts…
Abnormal blood sugar (glucose) levels, either lower or higher than the norm, appears to be linked with a faster progression…
Parkinson’s UK is paving the way for a future clinical trial that will continue to test a naturally occurring…